# Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China

> **NCT00781716** · NA · UNKNOWN · sponsor: **Beijing Chao Yang Hospital** · enrollment: 1020 (estimated)

## Conditions studied

- Myocardial Infarction
- Coronary Artery Disease

## Interventions

- **DEVICE:** Drug eluting coronary stent system

## Key facts

- **NCT ID:** NCT00781716
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 1020 (ESTIMATED)
- **Last updated:** 2008-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781716, "Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China". Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/clinical/NCT00781716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*